

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.44865092 |
| 2 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.44865092 |
| 3 | modulation by symbiont of host immune response (GO:0052553) | 4.44865092 |
| 4 | positive regulation by symbiont of host defense response (GO:0052509) | 4.44865092 |
| 5 | modulation by symbiont of host defense response (GO:0052031) | 4.44865092 |
| 6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.44865092 |
| 7 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.43088571 |
| 8 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.32863832 |
| 9 | protein localization to endosome (GO:0036010) | 4.19041041 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 3.96908210 |
| 11 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.94913389 |
| 12 | immunoglobulin mediated immune response (GO:0016064) | 3.79557251 |
| 13 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.62773896 |
| 14 | positive regulation of interferon-alpha production (GO:0032727) | 3.62484523 |
| 15 | COPI coating of Golgi vesicle (GO:0048205) | 3.59927949 |
| 16 | Golgi transport vesicle coating (GO:0048200) | 3.59927949 |
| 17 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.59164507 |
| 18 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.59164507 |
| 19 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.58501193 |
| 20 | pinocytosis (GO:0006907) | 3.45042478 |
| 21 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.41613534 |
| 22 | natural killer cell mediated immunity (GO:0002228) | 3.41613534 |
| 23 | regulation of interferon-alpha production (GO:0032647) | 3.39753684 |
| 24 | oligosaccharide catabolic process (GO:0009313) | 3.39715756 |
| 25 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.34660059 |
| 26 | macrophage activation involved in immune response (GO:0002281) | 3.33776446 |
| 27 | amino sugar catabolic process (GO:0046348) | 3.27245657 |
| 28 | response to peptidoglycan (GO:0032494) | 3.22628824 |
| 29 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.21252099 |
| 30 | regulation of leukocyte degranulation (GO:0043300) | 3.19618252 |
| 31 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.13353609 |
| 32 | regulation of mast cell degranulation (GO:0043304) | 3.12484063 |
| 33 | positive regulation of interferon-beta production (GO:0032728) | 3.08001974 |
| 34 | B cell mediated immunity (GO:0019724) | 3.05739229 |
| 35 | N-acetylneuraminate metabolic process (GO:0006054) | 3.04102979 |
| 36 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.03845719 |
| 37 | regulation of early endosome to late endosome transport (GO:2000641) | 3.03002808 |
| 38 | stress fiber assembly (GO:0043149) | 3.01839512 |
| 39 | negative regulation of interleukin-12 production (GO:0032695) | 2.99020427 |
| 40 | response to laminar fluid shear stress (GO:0034616) | 2.94639569 |
| 41 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.92941991 |
| 42 | positive regulation of receptor recycling (GO:0001921) | 2.92052280 |
| 43 | response to muramyl dipeptide (GO:0032495) | 2.91718248 |
| 44 | endosome to pigment granule transport (GO:0043485) | 2.91374127 |
| 45 | endosome to melanosome transport (GO:0035646) | 2.91374127 |
| 46 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.89805725 |
| 47 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.83881666 |
| 48 | keratan sulfate catabolic process (GO:0042340) | 2.82954625 |
| 49 | respiratory burst (GO:0045730) | 2.82751911 |
| 50 | mannose metabolic process (GO:0006013) | 2.81153880 |
| 51 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.80476043 |
| 52 | adhesion of symbiont to host (GO:0044406) | 2.79833935 |
| 53 | ceramide catabolic process (GO:0046514) | 2.79751527 |
| 54 | positive regulation of leukocyte degranulation (GO:0043302) | 2.79603945 |
| 55 | apoptotic cell clearance (GO:0043277) | 2.79421131 |
| 56 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.78600145 |
| 57 | actin nucleation (GO:0045010) | 2.77029638 |
| 58 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.76910840 |
| 59 | T cell apoptotic process (GO:0070231) | 2.76855984 |
| 60 | adhesion of symbiont to host cell (GO:0044650) | 2.76665451 |
| 61 | virion attachment to host cell (GO:0019062) | 2.76665451 |
| 62 | cellular response to arsenic-containing substance (GO:0071243) | 2.76503467 |
| 63 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.68672611 |
| 64 | response to interferon-alpha (GO:0035455) | 2.67573991 |
| 65 | response to host immune response (GO:0052572) | 2.67548777 |
| 66 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.67548777 |
| 67 | basement membrane organization (GO:0071711) | 2.64608948 |
| 68 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.64241475 |
| 69 | formation of translation preinitiation complex (GO:0001731) | 2.63860107 |
| 70 | positive regulation of protein dephosphorylation (GO:0035307) | 2.62756732 |
| 71 | pentose-phosphate shunt (GO:0006098) | 2.62032156 |
| 72 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.59733638 |
| 73 | glycosphingolipid catabolic process (GO:0046479) | 2.59482181 |
| 74 | detection of molecule of bacterial origin (GO:0032490) | 2.56584951 |
| 75 | hyaluronan catabolic process (GO:0030214) | 2.56191692 |
| 76 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.56004477 |
| 77 | lysosome organization (GO:0007040) | 2.55674409 |
| 78 | lytic vacuole organization (GO:0080171) | 2.55674409 |
| 79 | positive regulation of antigen processing and presentation (GO:0002579) | 2.55156949 |
| 80 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.54585665 |
| 81 | folic acid transport (GO:0015884) | 2.53869963 |
| 82 | regulation of integrin activation (GO:0033623) | 2.53487305 |
| 83 | glycolipid catabolic process (GO:0019377) | 2.52268639 |
| 84 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.52177011 |
| 85 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.51702601 |
| 86 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.51463112 |
| 87 | membrane lipid catabolic process (GO:0046466) | 2.50377117 |
| 88 | myeloid cell homeostasis (GO:0002262) | 2.48844688 |
| 89 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.48043487 |
| 90 | regulation of interferon-beta production (GO:0032648) | 2.47858696 |
| 91 | regulation of regulated secretory pathway (GO:1903305) | 2.47582104 |
| 92 | regulation of extracellular matrix disassembly (GO:0010715) | 2.46980702 |
| 93 | semaphorin-plexin signaling pathway (GO:0071526) | 2.46918769 |
| 94 | modulation by symbiont of host cellular process (GO:0044068) | 2.46843707 |
| 95 | regulation of protein heterodimerization activity (GO:0043497) | 2.46647659 |
| 96 | sphingolipid catabolic process (GO:0030149) | 2.46588107 |
| 97 | positive regulation of T cell apoptotic process (GO:0070234) | 2.45884442 |
| 98 | regulation of superoxide anion generation (GO:0032928) | 2.45559465 |
| 99 | barbed-end actin filament capping (GO:0051016) | 2.43043241 |
| 100 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.41693541 |
| 101 | amyloid precursor protein catabolic process (GO:0042987) | 2.41367570 |
| 102 | lymphocyte apoptotic process (GO:0070227) | 2.40376637 |
| 103 | skin morphogenesis (GO:0043589) | 2.40183873 |
| 104 | glycoside metabolic process (GO:0016137) | 2.39570100 |
| 105 | germinal center formation (GO:0002467) | 2.39324450 |
| 106 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.38459937 |
| 107 | regulation of macrophage cytokine production (GO:0010935) | 2.37699542 |
| 108 | embryonic process involved in female pregnancy (GO:0060136) | 2.37270509 |
| 109 | peptide catabolic process (GO:0043171) | 2.36637433 |
| 110 | myeloid cell activation involved in immune response (GO:0002275) | 2.36144526 |
| 111 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.36092170 |
| 112 | response to host (GO:0075136) | 2.35548188 |
| 113 | response to host defenses (GO:0052200) | 2.35548188 |
| 114 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.35548188 |
| 115 | positive regulation of nuclease activity (GO:0032075) | 2.35163310 |
| 116 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.34832006 |
| 117 | apoptotic process involved in morphogenesis (GO:0060561) | 2.34476783 |
| 118 | positive regulation of macrophage cytokine production (GO:0060907) | 2.34408314 |
| 119 | positive regulation of extracellular matrix organization (GO:1903055) | 2.34142664 |
| 120 | decidualization (GO:0046697) | 2.34099655 |
| 121 | protein retention in ER lumen (GO:0006621) | 2.33874006 |
| 122 | regulation of antigen processing and presentation (GO:0002577) | 2.33388424 |
| 123 | detection of other organism (GO:0098543) | 2.32644342 |
| 124 | response to interferon-beta (GO:0035456) | 2.32415038 |
| 125 | mature B cell differentiation involved in immune response (GO:0002313) | 2.31080113 |
| 126 | positive regulation of bone resorption (GO:0045780) | 2.30042280 |
| 127 | positive regulation of bone remodeling (GO:0046852) | 2.30042280 |
| 128 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.29835620 |
| 129 | cellular response to interferon-alpha (GO:0035457) | 2.29545581 |
| 130 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.29534580 |
| 131 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.29261711 |
| 132 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.29118369 |
| 133 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.29075244 |
| 134 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.28738076 |
| 135 | response to thyroid hormone (GO:0097066) | 2.28623284 |
| 136 | detection of external biotic stimulus (GO:0098581) | 2.28572013 |
| 137 | cell adhesion mediated by integrin (GO:0033627) | 2.28466670 |
| 138 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.28226617 |
| 139 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.27820885 |
| 140 | NADPH regeneration (GO:0006740) | 2.26794185 |
| 141 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.26726852 |
| 142 | glucose catabolic process (GO:0006007) | 2.26672006 |
| 143 | neutrophil mediated immunity (GO:0002446) | 2.26239366 |
| 144 | response to magnesium ion (GO:0032026) | 2.26054247 |
| 145 | leukocyte mediated cytotoxicity (GO:0001909) | 2.26023287 |
| 146 | positive regulation of mast cell activation (GO:0033005) | 2.25891941 |
| 147 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.25710911 |
| 148 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.25463932 |
| 149 | positive regulation of mast cell degranulation (GO:0043306) | 2.25463932 |
| 150 | NIK/NF-kappaB signaling (GO:0038061) | 2.25388736 |
| 151 | granulocyte activation (GO:0036230) | 2.25036989 |
| 152 | wound healing, spreading of epidermal cells (GO:0035313) | 2.24971301 |
| 153 | leukocyte apoptotic process (GO:0071887) | 2.24821081 |
| 154 | myeloid dendritic cell differentiation (GO:0043011) | 2.24447899 |
| 155 | low-density lipoprotein particle clearance (GO:0034383) | 2.24435496 |
| 156 | endothelial cell chemotaxis (GO:0035767) | 2.24033729 |
| 157 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.23795056 |
| 158 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.23530033 |
| 159 | regulation of nuclease activity (GO:0032069) | 2.22772399 |
| 160 | folic acid metabolic process (GO:0046655) | 2.22170679 |
| 161 | endoplasmic reticulum unfolded protein response (GO:0030968) | 2.21973886 |
| 162 | negative regulation of cell size (GO:0045792) | 2.21160363 |
| 163 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.21093259 |
| 164 | negative regulation of cell killing (GO:0031342) | 2.21093259 |
| 165 | cortical actin cytoskeleton organization (GO:0030866) | 2.21069616 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.37212813 |
| 2 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.31183259 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.23494697 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.71861467 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.65555015 |
| 6 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.42481700 |
| 7 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.42301416 |
| 8 | TFEB_21752829_ChIP-Seq_HELA_Human | 2.29588668 |
| 9 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.20063676 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.15852939 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.13379388 |
| 12 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.12224600 |
| 13 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.09766538 |
| 14 | * MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.06384576 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.05607030 |
| 16 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.04852117 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.99914867 |
| 18 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.96717598 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.95241096 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.90111972 |
| 21 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.86855534 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.84909865 |
| 23 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.83317433 |
| 24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.81889726 |
| 25 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.80402783 |
| 26 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.79416322 |
| 27 | MYC_22102868_ChIP-Seq_BL_Human | 1.76615475 |
| 28 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.76224345 |
| 29 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.72121219 |
| 30 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63816856 |
| 31 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63587423 |
| 32 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.60830462 |
| 33 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.60625275 |
| 34 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57681919 |
| 35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.56486467 |
| 36 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55350337 |
| 37 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.54329136 |
| 38 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.52730873 |
| 39 | KDM2B_26808549_Chip-Seq_K562_Human | 1.52380476 |
| 40 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.52151639 |
| 41 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.52133135 |
| 42 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.51357758 |
| 43 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.47346539 |
| 44 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.46958284 |
| 45 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.45274890 |
| 46 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.45214101 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.43633172 |
| 48 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.42433810 |
| 49 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.42405430 |
| 50 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.40769964 |
| 51 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.39747554 |
| 52 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.39649953 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.39485464 |
| 54 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.38098766 |
| 55 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.37871676 |
| 56 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.34662430 |
| 57 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.33902427 |
| 58 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.33345911 |
| 59 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.32291542 |
| 60 | MAF_26560356_Chip-Seq_TH2_Human | 1.31631143 |
| 61 | MAF_26560356_Chip-Seq_TH1_Human | 1.31064374 |
| 62 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.30176891 |
| 63 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29927829 |
| 64 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29671281 |
| 65 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.26923411 |
| 66 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.26635469 |
| 67 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.26612371 |
| 68 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.26060534 |
| 69 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.25983348 |
| 70 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.25019255 |
| 71 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.24879866 |
| 72 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.24185076 |
| 73 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.22029418 |
| 74 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.21979183 |
| 75 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.21835210 |
| 76 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.21715639 |
| 77 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.21544493 |
| 78 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21173129 |
| 79 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.20981536 |
| 80 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.20938660 |
| 81 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.20632911 |
| 82 | P68_20966046_ChIP-Seq_HELA_Human | 1.19697839 |
| 83 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.19495186 |
| 84 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.19166608 |
| 85 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.18789315 |
| 86 | SPI1_23127762_ChIP-Seq_K562_Human | 1.18455746 |
| 87 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.17991863 |
| 88 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.17716355 |
| 89 | ATF3_27146783_Chip-Seq_COLON_Human | 1.17401752 |
| 90 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.17130237 |
| 91 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.16888139 |
| 92 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.16718191 |
| 93 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.16467395 |
| 94 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15978084 |
| 95 | UTX_26944678_Chip-Seq_JUKART_Human | 1.15939940 |
| 96 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15619028 |
| 97 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.15434811 |
| 98 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.15248482 |
| 99 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.15174491 |
| 100 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.14583783 |
| 101 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.13707868 |
| 102 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.13581646 |
| 103 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.13424692 |
| 104 | MYB_26560356_Chip-Seq_TH2_Human | 1.13409283 |
| 105 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.12402787 |
| 106 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.12326044 |
| 107 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11973680 |
| 108 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.11901120 |
| 109 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.11526242 |
| 110 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.11296437 |
| 111 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10027883 |
| 112 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09828042 |
| 113 | MYB_26560356_Chip-Seq_TH1_Human | 1.08722496 |
| 114 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.08335248 |
| 115 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07896719 |
| 116 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07417393 |
| 117 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06911533 |
| 118 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.05802258 |
| 119 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.05369790 |
| 120 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04788023 |
| 121 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.04786124 |
| 122 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.04227851 |
| 123 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04051997 |
| 124 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.03516669 |
| 125 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.03323002 |
| 126 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.02979244 |
| 127 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02221106 |
| 128 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.02212690 |
| 129 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.01436382 |
| 130 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.01295861 |
| 131 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.01263757 |
| 132 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00650837 |
| 133 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99812581 |
| 134 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.99489322 |
| 135 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98351332 |
| 136 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.98285426 |
| 137 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.97674566 |
| 138 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.97231517 |
| 139 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.97013066 |
| 140 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.96722298 |
| 141 | AR_21909140_ChIP-Seq_LNCAP_Human | 0.95985837 |
| 142 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.94487402 |
| 143 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.93892656 |
| 144 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93781673 |
| 145 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92899792 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 4.74155490 |
| 2 | MP0003172_abnormal_lysosome_physiology | 3.28225595 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 3.00379420 |
| 4 | MP0009840_abnormal_foam_cell | 2.93866836 |
| 5 | MP0005451_abnormal_body_composition | 2.61175955 |
| 6 | MP0003436_decreased_susceptibility_to | 2.41862761 |
| 7 | MP0005257_abnormal_intraocular_pressure | 2.41553434 |
| 8 | MP0001835_abnormal_antigen_presentation | 2.35239652 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.26755149 |
| 10 | MP0003303_peritoneal_inflammation | 2.24259295 |
| 11 | MP0010307_abnormal_tumor_latency | 2.23590680 |
| 12 | MP0006082_CNS_inflammation | 2.16132920 |
| 13 | MP0002877_abnormal_melanocyte_morpholog | 2.15536155 |
| 14 | MP0001958_emphysema | 2.01984360 |
| 15 | MP0002419_abnormal_innate_immunity | 1.93093868 |
| 16 | MP0003300_gastrointestinal_ulcer | 1.83137121 |
| 17 | MP0010352_gastrointestinal_tract_polyps | 1.80403239 |
| 18 | MP0003693_abnormal_embryo_hatching | 1.76764820 |
| 19 | MP0009278_abnormal_bone_marrow | 1.73271865 |
| 20 | MP0003566_abnormal_cell_adhesion | 1.73031142 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.71938376 |
| 22 | MP0005000_abnormal_immune_tolerance | 1.71445476 |
| 23 | MP0009785_altered_susceptibility_to | 1.70078318 |
| 24 | MP0000858_altered_metastatic_potential | 1.64506839 |
| 25 | MP0002452_abnormal_antigen_presenting | 1.63969081 |
| 26 | MP0005025_abnormal_response_to | 1.58541741 |
| 27 | MP0009333_abnormal_splenocyte_physiolog | 1.57224461 |
| 28 | MP0005464_abnormal_platelet_physiology | 1.55875729 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.52972933 |
| 30 | MP0003448_altered_tumor_morphology | 1.51611573 |
| 31 | MP0000371_diluted_coat_color | 1.51244274 |
| 32 | MP0005023_abnormal_wound_healing | 1.49604396 |
| 33 | MP0000490_abnormal_crypts_of | 1.48910484 |
| 34 | MP0004947_skin_inflammation | 1.48519574 |
| 35 | MP0003453_abnormal_keratinocyte_physiol | 1.46714660 |
| 36 | MP0000685_abnormal_immune_system | 1.45810490 |
| 37 | MP0002148_abnormal_hypersensitivity_rea | 1.45700864 |
| 38 | MP0005397_hematopoietic_system_phenotyp | 1.45301069 |
| 39 | MP0001545_abnormal_hematopoietic_system | 1.45301069 |
| 40 | MP0000569_abnormal_digit_pigmentation | 1.43413598 |
| 41 | MP0002254_reproductive_system_inflammat | 1.42472312 |
| 42 | MP0005171_absent_coat_pigmentation | 1.41807905 |
| 43 | MP0002723_abnormal_immune_serum | 1.39668850 |
| 44 | MP0003075_altered_response_to | 1.36229214 |
| 45 | MP0001819_abnormal_immune_cell | 1.35569730 |
| 46 | MP0002420_abnormal_adaptive_immunity | 1.34597250 |
| 47 | MP0005387_immune_system_phenotype | 1.33060877 |
| 48 | MP0001790_abnormal_immune_system | 1.33060877 |
| 49 | MP0001800_abnormal_humoral_immune | 1.30612060 |
| 50 | MP0002405_respiratory_system_inflammati | 1.30542665 |
| 51 | MP0005076_abnormal_cell_differentiation | 1.29677944 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.28959675 |
| 53 | MP0005174_abnormal_tail_pigmentation | 1.24626546 |
| 54 | MP0001348_abnormal_lacrimal_gland | 1.24246968 |
| 55 | MP0003329_amyloid_beta_deposits | 1.22235628 |
| 56 | MP0002998_abnormal_bone_remodeling | 1.20446755 |
| 57 | MP0006054_spinal_hemorrhage | 1.20294538 |
| 58 | MP0001845_abnormal_inflammatory_respons | 1.20138826 |
| 59 | MP0004808_abnormal_hematopoietic_stem | 1.19661067 |
| 60 | MP0004858_abnormal_nervous_system | 1.19375342 |
| 61 | MP0005310_abnormal_salivary_gland | 1.18534041 |
| 62 | MP0000689_abnormal_spleen_morphology | 1.17887832 |
| 63 | MP0002396_abnormal_hematopoietic_system | 1.17325227 |
| 64 | MP0004233_abnormal_muscle_weight | 1.15373582 |
| 65 | MP0004381_abnormal_hair_follicle | 1.14568661 |
| 66 | MP0003279_aneurysm | 1.14200777 |
| 67 | MP0010234_abnormal_vibrissa_follicle | 1.14119137 |
| 68 | MP0000767_abnormal_smooth_muscle | 1.14050484 |
| 69 | MP0005671_abnormal_response_to | 1.13598687 |
| 70 | MP0001853_heart_inflammation | 1.12291297 |
| 71 | MP0000343_altered_response_to | 1.10829487 |
| 72 | MP0004957_abnormal_blastocyst_morpholog | 1.09614786 |
| 73 | MP0003111_abnormal_nucleus_morphology | 1.08863886 |
| 74 | MP0002166_altered_tumor_susceptibility | 1.07251856 |
| 75 | MP0005275_abnormal_skin_tensile | 1.07204544 |
| 76 | MP0002722_abnormal_immune_system | 1.06708109 |
| 77 | MP0000015_abnormal_ear_pigmentation | 1.06472027 |
| 78 | MP0000716_abnormal_immune_system | 1.06107655 |
| 79 | MP0003828_pulmonary_edema | 1.05228277 |
| 80 | MP0002398_abnormal_bone_marrow | 1.04605246 |
| 81 | MP0004510_myositis | 1.04223634 |
| 82 | MP0008469_abnormal_protein_level | 1.03791474 |
| 83 | MP0003091_abnormal_cell_migration | 1.01929745 |
| 84 | MP0010155_abnormal_intestine_physiology | 1.01879700 |
| 85 | MP0002933_joint_inflammation | 1.01861001 |
| 86 | MP0000465_gastrointestinal_hemorrhage | 1.01388413 |
| 87 | MP0005390_skeleton_phenotype | 1.00324053 |
| 88 | MP0003795_abnormal_bone_structure | 0.99365896 |
| 89 | MP0000372_irregular_coat_pigmentation | 0.99342361 |
| 90 | MP0002429_abnormal_blood_cell | 0.99158758 |
| 91 | MP0009384_cardiac_valve_regurgitation | 0.98114302 |
| 92 | MP0000920_abnormal_myelination | 0.91720182 |
| 93 | MP0000358_abnormal_cell_content/ | 0.91135525 |
| 94 | MP0002896_abnormal_bone_mineralization | 0.90568165 |
| 95 | MP0008260_abnormal_autophagy | 0.90552875 |
| 96 | MP0000604_amyloidosis | 0.90259563 |
| 97 | MP0005503_abnormal_tendon_morphology | 0.89269496 |
| 98 | MP0002075_abnormal_coat/hair_pigmentati | 0.89137119 |
| 99 | MP0005409_darkened_coat_color | 0.88291990 |
| 100 | MP0003186_abnormal_redox_activity | 0.88058887 |
| 101 | MP0004185_abnormal_adipocyte_glucose | 0.87927917 |
| 102 | MP0003724_increased_susceptibility_to | 0.87744443 |
| 103 | MP0003690_abnormal_glial_cell | 0.87439770 |
| 104 | MP0008007_abnormal_cellular_replicative | 0.86933825 |
| 105 | MP0003634_abnormal_glial_cell | 0.84837110 |
| 106 | MP0009643_abnormal_urine_homeostasis | 0.84200011 |
| 107 | MP0003077_abnormal_cell_cycle | 0.84195933 |
| 108 | MP0000747_muscle_weakness | 0.81875132 |
| 109 | MP0001873_stomach_inflammation | 0.81626800 |
| 110 | MP0002019_abnormal_tumor_incidence | 0.80042297 |
| 111 | MP0002006_tumorigenesis | 0.79840929 |
| 112 | MP0005621_abnormal_cell_physiology | 0.79724161 |
| 113 | MP0004272_abnormal_basement_membrane | 0.79716952 |
| 114 | MP0002136_abnormal_kidney_physiology | 0.79466607 |
| 115 | MP0000733_abnormal_muscle_development | 0.78793602 |
| 116 | MP0001849_ear_inflammation | 0.78011094 |
| 117 | MP0001542_abnormal_bone_strength | 0.77987359 |
| 118 | MP0002060_abnormal_skin_morphology | 0.77180308 |
| 119 | MP0001243_abnormal_dermal_layer | 0.75709020 |
| 120 | MP0001756_abnormal_urination | 0.75163269 |
| 121 | MP0005083_abnormal_biliary_tract | 0.74722156 |
| 122 | MP0001186_pigmentation_phenotype | 0.74009008 |
| 123 | MP0002089_abnormal_postnatal_growth/wei | 0.73114906 |
| 124 | MP0005075_abnormal_melanosome_morpholog | 0.72942100 |
| 125 | MP0005595_abnormal_vascular_smooth | 0.72777425 |
| 126 | MP0000313_abnormal_cell_death | 0.70955913 |
| 127 | MP0000598_abnormal_liver_morphology | 0.70380203 |
| 128 | MP0002135_abnormal_kidney_morphology | 0.70324933 |
| 129 | MP0000750_abnormal_muscle_regeneration | 0.67275286 |
| 130 | MP0005384_cellular_phenotype | 0.65950866 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vacuolated lymphocytes (HP:0001922) | 5.56537089 |
| 2 | Increased cerebral lipofuscin (HP:0011813) | 5.55489339 |
| 3 | Dysostosis multiplex (HP:0000943) | 5.15835941 |
| 4 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.82712684 |
| 5 | Abnormality of glycolipid metabolism (HP:0010969) | 4.61302557 |
| 6 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.61302557 |
| 7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.61302557 |
| 8 | Mucopolysacchariduria (HP:0008155) | 4.43592897 |
| 9 | Urinary glycosaminoglycan excretion (HP:0003541) | 4.43592897 |
| 10 | Recurrent abscess formation (HP:0002722) | 4.30380613 |
| 11 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 4.21744618 |
| 12 | Abnormality of polysaccharide metabolism (HP:0011012) | 4.21744618 |
| 13 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 4.21744618 |
| 14 | Abnormality of macrophages (HP:0004311) | 3.90558832 |
| 15 | Premature rupture of membranes (HP:0001788) | 3.79546207 |
| 16 | Cervical subluxation (HP:0003308) | 3.67752283 |
| 17 | Vertebral compression fractures (HP:0002953) | 3.64551521 |
| 18 | Eczematoid dermatitis (HP:0000976) | 3.53584859 |
| 19 | Recurrent bacterial skin infections (HP:0005406) | 3.51418715 |
| 20 | Protrusio acetabuli (HP:0003179) | 3.20143102 |
| 21 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.14362129 |
| 22 | Axonal loss (HP:0003447) | 3.02707584 |
| 23 | Cerebral aneurysm (HP:0004944) | 2.70742218 |
| 24 | Disinhibition (HP:0000734) | 2.68766325 |
| 25 | Pustule (HP:0200039) | 2.68535940 |
| 26 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.66645473 |
| 27 | Hyperacusis (HP:0010780) | 2.66443315 |
| 28 | Ankle contracture (HP:0006466) | 2.64891169 |
| 29 | Loss of speech (HP:0002371) | 2.61884872 |
| 30 | Agnosia (HP:0010524) | 2.60270142 |
| 31 | Interstitial pulmonary disease (HP:0006530) | 2.58886829 |
| 32 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.58286653 |
| 33 | Osteolytic defects of the hand bones (HP:0009699) | 2.58286653 |
| 34 | Nuclear cataract (HP:0100018) | 2.54587115 |
| 35 | Neurofibrillary tangles (HP:0002185) | 2.52642981 |
| 36 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.46189979 |
| 37 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.45421488 |
| 38 | Personality changes (HP:0000751) | 2.44749718 |
| 39 | Petechiae (HP:0000967) | 2.41942920 |
| 40 | Gingivitis (HP:0000230) | 2.40902937 |
| 41 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.35885669 |
| 42 | Joint stiffness (HP:0001387) | 2.34572551 |
| 43 | Autoimmune thrombocytopenia (HP:0001973) | 2.33886192 |
| 44 | Achilles tendon contracture (HP:0001771) | 2.31126138 |
| 45 | Pathologic fracture (HP:0002756) | 2.29979011 |
| 46 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.27969456 |
| 47 | Beaking of vertebral bodies (HP:0004568) | 2.27080363 |
| 48 | Cerebral inclusion bodies (HP:0100314) | 2.24206484 |
| 49 | Myositis (HP:0100614) | 2.21709952 |
| 50 | Poor head control (HP:0002421) | 2.21029240 |
| 51 | Global brain atrophy (HP:0002283) | 2.20926910 |
| 52 | Hand muscle atrophy (HP:0009130) | 2.20722897 |
| 53 | Asymmetric septal hypertrophy (HP:0001670) | 2.17770519 |
| 54 | Basal ganglia calcification (HP:0002135) | 2.17374290 |
| 55 | Progressive neurologic deterioration (HP:0002344) | 2.17001779 |
| 56 | Obstructive lung disease (HP:0006536) | 2.13949512 |
| 57 | Chronic obstructive pulmonary disease (HP:0006510) | 2.13949512 |
| 58 | Deformed sella turcica (HP:0002681) | 2.11814793 |
| 59 | Systemic lupus erythematosus (HP:0002725) | 2.10318858 |
| 60 | Prolonged neonatal jaundice (HP:0006579) | 2.09414983 |
| 61 | Spontaneous hematomas (HP:0007420) | 2.09285419 |
| 62 | Tetraparesis (HP:0002273) | 2.06954032 |
| 63 | Gastrointestinal stroma tumor (HP:0100723) | 2.06249348 |
| 64 | Increased connective tissue (HP:0009025) | 2.05342324 |
| 65 | Thrombocytosis (HP:0001894) | 2.03677557 |
| 66 | Neuronal loss in central nervous system (HP:0002529) | 2.03475148 |
| 67 | Abnormality of the Achilles tendon (HP:0005109) | 2.02954248 |
| 68 | Spinal muscular atrophy (HP:0007269) | 2.01826408 |
| 69 | Purpura (HP:0000979) | 2.01635730 |
| 70 | Diminished motivation (HP:0000745) | 2.00466400 |
| 71 | Distal lower limb muscle weakness (HP:0009053) | 2.00256268 |
| 72 | Conjunctival telangiectasia (HP:0000524) | 2.00172672 |
| 73 | Recurrent skin infections (HP:0001581) | 1.98148535 |
| 74 | Cardiomegaly (HP:0001640) | 1.97587575 |
| 75 | Ocular albinism (HP:0001107) | 1.97542412 |
| 76 | Broad face (HP:0000283) | 1.97195412 |
| 77 | Hepatosplenomegaly (HP:0001433) | 1.95525486 |
| 78 | Myocardial infarction (HP:0001658) | 1.95093031 |
| 79 | Distal upper limb amyotrophy (HP:0007149) | 1.93383784 |
| 80 | Upper limb amyotrophy (HP:0009129) | 1.93383784 |
| 81 | Recurrent fungal infections (HP:0002841) | 1.92523267 |
| 82 | Soft skin (HP:0000977) | 1.92338071 |
| 83 | Albinism (HP:0001022) | 1.92015180 |
| 84 | Spinal rigidity (HP:0003306) | 1.91691793 |
| 85 | Thoracic kyphosis (HP:0002942) | 1.90695548 |
| 86 | Cellulitis (HP:0100658) | 1.89510792 |
| 87 | Bone pain (HP:0002653) | 1.88223679 |
| 88 | Distal lower limb amyotrophy (HP:0008944) | 1.86681798 |
| 89 | Ovoid vertebral bodies (HP:0003300) | 1.86577987 |
| 90 | Severe short stature (HP:0003510) | 1.85985149 |
| 91 | Entropion (HP:0000621) | 1.85632316 |
| 92 | Peritonitis (HP:0002586) | 1.85124181 |
| 93 | Amyloidosis (HP:0011034) | 1.83874939 |
| 94 | Aneurysm (HP:0002617) | 1.83865454 |
| 95 | Dilatation of the ascending aorta (HP:0005111) | 1.83608138 |
| 96 | Emphysema (HP:0002097) | 1.82156958 |
| 97 | Supranuclear gaze palsy (HP:0000605) | 1.80776718 |
| 98 | Abnormality of the acetabulum (HP:0003170) | 1.80659234 |
| 99 | Colitis (HP:0002583) | 1.80519828 |
| 100 | Restrictive lung disease (HP:0002091) | 1.80478460 |
| 101 | Genu recurvatum (HP:0002816) | 1.80227351 |
| 102 | Mediastinal lymphadenopathy (HP:0100721) | 1.79937036 |
| 103 | Nonimmune hydrops fetalis (HP:0001790) | 1.76604452 |
| 104 | J-shaped sella turcica (HP:0002680) | 1.75263570 |
| 105 | Thin bony cortex (HP:0002753) | 1.74830687 |
| 106 | Abnormal platelet function (HP:0011869) | 1.74479400 |
| 107 | Impaired platelet aggregation (HP:0003540) | 1.74479400 |
| 108 | Bladder diverticulum (HP:0000015) | 1.74201293 |
| 109 | Abnormality of the umbilical cord (HP:0010881) | 1.73870852 |
| 110 | Long toe (HP:0010511) | 1.72901044 |
| 111 | Hematochezia (HP:0002573) | 1.72817373 |
| 112 | Wormian bones (HP:0002645) | 1.71396154 |
| 113 | Abnormality of the odontoid process (HP:0003310) | 1.71382992 |
| 114 | Premature loss of primary teeth (HP:0006323) | 1.71030410 |
| 115 | Periodontitis (HP:0000704) | 1.69784996 |
| 116 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.69039088 |
| 117 | Osteomyelitis (HP:0002754) | 1.68771350 |
| 118 | Apathy (HP:0000741) | 1.68460885 |
| 119 | Abnormality of the thoracic spine (HP:0100711) | 1.68025709 |
| 120 | Natal tooth (HP:0000695) | 1.67640312 |
| 121 | Biconcave vertebral bodies (HP:0004586) | 1.66988770 |
| 122 | Flat acetabular roof (HP:0003180) | 1.66970413 |
| 123 | Hypoplasia of the odontoid process (HP:0003311) | 1.66351201 |
| 124 | Spondylolisthesis (HP:0003302) | 1.66187823 |
| 125 | Orchitis (HP:0100796) | 1.65538622 |
| 126 | Upper motor neuron abnormality (HP:0002127) | 1.64078316 |
| 127 | Ulnar bowing (HP:0003031) | 1.62774824 |
| 128 | Blue sclerae (HP:0000592) | 1.62725269 |
| 129 | Increased serum ferritin (HP:0003281) | 1.61340291 |
| 130 | Abnormality of skull ossification (HP:0002703) | 1.61278286 |
| 131 | Short nail (HP:0001799) | 1.61150774 |
| 132 | Mitral regurgitation (HP:0001653) | 1.61019156 |
| 133 | Generalized amyotrophy (HP:0003700) | 1.59634239 |
| 134 | Sparse lateral eyebrow (HP:0005338) | 1.58996241 |
| 135 | Elbow flexion contracture (HP:0002987) | 1.58254723 |
| 136 | Persistence of primary teeth (HP:0006335) | 1.57118790 |
| 137 | Increased variability in muscle fiber diameter (HP:0003557) | 1.56850772 |
| 138 | Stridor (HP:0010307) | 1.56823477 |
| 139 | Fragile skin (HP:0001030) | 1.56326899 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 3.61496710 |
| 2 | ERN1 | 3.36669648 |
| 3 | PRPF4B | 2.99680361 |
| 4 | TRIB3 | 2.81845872 |
| 5 | SCYL2 | 2.76217020 |
| 6 | SIK1 | 2.48520715 |
| 7 | BLK | 2.45109306 |
| 8 | PIM2 | 2.38398118 |
| 9 | KIT | 2.34175261 |
| 10 | TBK1 | 2.30264756 |
| 11 | PKN2 | 2.11154614 |
| 12 | SMG1 | 2.10573861 |
| 13 | MAP3K13 | 2.08226370 |
| 14 | IRAK3 | 2.03183914 |
| 15 | ICK | 2.00997434 |
| 16 | PAK4 | 1.84275045 |
| 17 | BUB1 | 1.84192057 |
| 18 | EPHA2 | 1.81794548 |
| 19 | TYK2 | 1.80831709 |
| 20 | RPS6KA4 | 1.70742772 |
| 21 | MAP4K1 | 1.67688730 |
| 22 | LRRK2 | 1.67215718 |
| 23 | PRKD2 | 1.62490749 |
| 24 | TESK2 | 1.62361047 |
| 25 | WEE1 | 1.60162213 |
| 26 | TGFBR2 | 1.58841854 |
| 27 | MAP2K3 | 1.57448578 |
| 28 | TTN | 1.55070714 |
| 29 | ZAP70 | 1.49672722 |
| 30 | CDC42BPA | 1.47237640 |
| 31 | DDR2 | 1.46546715 |
| 32 | NEK2 | 1.45365940 |
| 33 | MAP3K3 | 1.43435575 |
| 34 | EEF2K | 1.41843132 |
| 35 | CAMKK2 | 1.34749724 |
| 36 | FGFR4 | 1.34334655 |
| 37 | IKBKB | 1.28013834 |
| 38 | FLT3 | 1.27653662 |
| 39 | IRAK4 | 1.26837116 |
| 40 | STK10 | 1.23704242 |
| 41 | KDR | 1.23176456 |
| 42 | NEK9 | 1.21909230 |
| 43 | TESK1 | 1.20241755 |
| 44 | CSF1R | 1.17906297 |
| 45 | JAK3 | 1.14503843 |
| 46 | MAP3K11 | 1.13743832 |
| 47 | MAP3K8 | 1.11380098 |
| 48 | PTK6 | 1.10029739 |
| 49 | PDPK1 | 1.07818547 |
| 50 | MAP3K10 | 1.05005657 |
| 51 | BMX | 1.03054650 |
| 52 | PIM1 | 1.01904208 |
| 53 | TAOK1 | 1.01897658 |
| 54 | TNK2 | 1.00116259 |
| 55 | TLK1 | 0.99664325 |
| 56 | RIPK4 | 0.99437668 |
| 57 | TAOK3 | 0.99425491 |
| 58 | IKBKE | 0.98489108 |
| 59 | MAP3K1 | 0.96107559 |
| 60 | CAMK1D | 0.95903639 |
| 61 | MOS | 0.91106047 |
| 62 | PASK | 0.90324309 |
| 63 | PDGFRA | 0.90207015 |
| 64 | MARK2 | 0.88501028 |
| 65 | HCK | 0.87645260 |
| 66 | EIF2AK3 | 0.87586144 |
| 67 | PRKD3 | 0.87529750 |
| 68 | RPS6KA2 | 0.86658397 |
| 69 | SIK3 | 0.86598971 |
| 70 | SIK2 | 0.85455890 |
| 71 | MST1R | 0.85245156 |
| 72 | KSR2 | 0.85065447 |
| 73 | ABL2 | 0.84709479 |
| 74 | BTK | 0.83423568 |
| 75 | MAPK11 | 0.82808674 |
| 76 | MATK | 0.82324722 |
| 77 | BRSK2 | 0.81741086 |
| 78 | CSK | 0.81593490 |
| 79 | ARAF | 0.80888489 |
| 80 | MAP2K2 | 0.80669029 |
| 81 | MAP3K6 | 0.79373670 |
| 82 | PAK2 | 0.76688873 |
| 83 | CDK12 | 0.75506591 |
| 84 | JAK1 | 0.75382871 |
| 85 | TAOK2 | 0.75321434 |
| 86 | FGR | 0.75301259 |
| 87 | LYN | 0.71046738 |
| 88 | PTK2 | 0.70310430 |
| 89 | RIPK1 | 0.70160145 |
| 90 | ACVR1B | 0.68429985 |
| 91 | IRAK2 | 0.67441595 |
| 92 | EPHB1 | 0.66835905 |
| 93 | MAP3K14 | 0.66829835 |
| 94 | EIF2AK1 | 0.66243701 |
| 95 | PDK1 | 0.64456945 |
| 96 | PAK1 | 0.64186699 |
| 97 | RPS6KC1 | 0.64123013 |
| 98 | RPS6KL1 | 0.64123013 |
| 99 | SYK | 0.63064729 |
| 100 | CDK7 | 0.62021705 |
| 101 | DYRK1B | 0.60724394 |
| 102 | PRKG2 | 0.60285899 |
| 103 | CHUK | 0.59875471 |
| 104 | MARK3 | 0.59822047 |
| 105 | CDK6 | 0.59757883 |
| 106 | LCK | 0.59612533 |
| 107 | MAPK7 | 0.59520827 |
| 108 | LMTK2 | 0.58839979 |
| 109 | DAPK3 | 0.58313602 |
| 110 | RPS6KB2 | 0.57085630 |
| 111 | MAPK12 | 0.56394664 |
| 112 | TEC | 0.55521768 |
| 113 | FES | 0.55071762 |
| 114 | MAPKAPK3 | 0.54975836 |
| 115 | PDGFRB | 0.54844650 |
| 116 | TRPM7 | 0.54479700 |
| 117 | HIPK2 | 0.54179620 |
| 118 | STK38 | 0.53848439 |
| 119 | MAP2K6 | 0.51742118 |
| 120 | AURKB | 0.51583320 |
| 121 | LATS2 | 0.51491754 |
| 122 | STK4 | 0.49787147 |
| 123 | MTOR | 0.49108660 |
| 124 | BCKDK | 0.48496644 |
| 125 | NEK1 | 0.47934587 |
| 126 | GRK6 | 0.47262833 |
| 127 | PLK1 | 0.46689109 |
| 128 | RPS6KA6 | 0.46169474 |
| 129 | MAP3K7 | 0.46088878 |
| 130 | ALK | 0.44907660 |
| 131 | CDK4 | 0.44513100 |
| 132 | JAK2 | 0.44263268 |
| 133 | RET | 0.43997209 |
| 134 | LIMK1 | 0.43660232 |
| 135 | STK3 | 0.42843870 |
| 136 | ABL1 | 0.42745182 |
| 137 | TYRO3 | 0.42657488 |
| 138 | DYRK3 | 0.42623931 |
| 139 | MET | 0.41960397 |
| 140 | PRKD1 | 0.40449123 |
| 141 | CAMKK1 | 0.38561178 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Lysosome_Homo sapiens_hsa04142 | 3.72193923 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 3.67275920 |
| 3 | Other glycan degradation_Homo sapiens_hsa00511 | 3.48788412 |
| 4 | * Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.14128332 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.00155491 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.89568933 |
| 7 | Proteasome_Homo sapiens_hsa03050 | 1.64297943 |
| 8 | Phagosome_Homo sapiens_hsa04145 | 1.63511197 |
| 9 | Legionellosis_Homo sapiens_hsa05134 | 1.61881215 |
| 10 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.60257888 |
| 11 | Tuberculosis_Homo sapiens_hsa05152 | 1.58742203 |
| 12 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.56519025 |
| 13 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.55773635 |
| 14 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.53058417 |
| 15 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.51685558 |
| 16 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.49777219 |
| 17 | DNA replication_Homo sapiens_hsa03030 | 1.49750647 |
| 18 | Apoptosis_Homo sapiens_hsa04210 | 1.49564394 |
| 19 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.44874091 |
| 20 | Shigellosis_Homo sapiens_hsa05131 | 1.40299985 |
| 21 | Galactose metabolism_Homo sapiens_hsa00052 | 1.40023532 |
| 22 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.38631468 |
| 23 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.37707405 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.36450071 |
| 25 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.35948844 |
| 26 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.35886877 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.28801002 |
| 28 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.27946625 |
| 29 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.27525851 |
| 30 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.24743224 |
| 31 | Allograft rejection_Homo sapiens_hsa05330 | 1.20563828 |
| 32 | Measles_Homo sapiens_hsa05162 | 1.19336415 |
| 33 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.19157595 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.17946897 |
| 35 | Pertussis_Homo sapiens_hsa05133 | 1.17266724 |
| 36 | Ribosome_Homo sapiens_hsa03010 | 1.17012811 |
| 37 | Base excision repair_Homo sapiens_hsa03410 | 1.13247737 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.12002557 |
| 39 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.11029164 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.10126363 |
| 41 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.09792027 |
| 42 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.07941800 |
| 43 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.06895394 |
| 44 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.06535937 |
| 45 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.06245794 |
| 46 | Sulfur relay system_Homo sapiens_hsa04122 | 1.01538612 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.00265667 |
| 48 | Bladder cancer_Homo sapiens_hsa05219 | 1.00128174 |
| 49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.99880423 |
| 50 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.99792100 |
| 51 | Mismatch repair_Homo sapiens_hsa03430 | 0.99726602 |
| 52 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.99353492 |
| 53 | Prion diseases_Homo sapiens_hsa05020 | 0.98435176 |
| 54 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.97966867 |
| 55 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.96547391 |
| 56 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.96283415 |
| 57 | Influenza A_Homo sapiens_hsa05164 | 0.95796828 |
| 58 | Viral myocarditis_Homo sapiens_hsa05416 | 0.95585165 |
| 59 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.95267175 |
| 60 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.94336780 |
| 61 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.94224334 |
| 62 | Salmonella infection_Homo sapiens_hsa05132 | 0.93589005 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.93546242 |
| 64 | Asthma_Homo sapiens_hsa05310 | 0.93299681 |
| 65 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.93131124 |
| 66 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.92676476 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90096750 |
| 68 | Hepatitis B_Homo sapiens_hsa05161 | 0.89322775 |
| 69 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.88460845 |
| 70 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.87440406 |
| 71 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.86928849 |
| 72 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.83332526 |
| 73 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.82477557 |
| 74 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82157185 |
| 75 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.81866146 |
| 76 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.81194874 |
| 77 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.80412953 |
| 78 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79720314 |
| 79 | Endometrial cancer_Homo sapiens_hsa05213 | 0.79538342 |
| 80 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.75266856 |
| 81 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.75080458 |
| 82 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.74896739 |
| 83 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.74322502 |
| 84 | RNA transport_Homo sapiens_hsa03013 | 0.73210037 |
| 85 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.72897588 |
| 86 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.72336590 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70964184 |
| 88 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.69795726 |
| 89 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.69689561 |
| 90 | Cell cycle_Homo sapiens_hsa04110 | 0.69574751 |
| 91 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.69400610 |
| 92 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.69079065 |
| 93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.68820445 |
| 94 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.68241053 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.67842011 |
| 96 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.67675756 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.67276821 |
| 98 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.67257718 |
| 99 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.67243404 |
| 100 | RNA polymerase_Homo sapiens_hsa03020 | 0.67202183 |
| 101 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.66406991 |
| 102 | Glioma_Homo sapiens_hsa05214 | 0.64868209 |
| 103 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.64404200 |
| 104 | Amoebiasis_Homo sapiens_hsa05146 | 0.63985190 |
| 105 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.62711441 |
| 106 | Prostate cancer_Homo sapiens_hsa05215 | 0.62686492 |
| 107 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62109839 |
| 108 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.62073946 |
| 109 | Endocytosis_Homo sapiens_hsa04144 | 0.61715396 |
| 110 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.61353690 |
| 111 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.61268466 |
| 112 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60786558 |
| 113 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60156918 |
| 114 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60065318 |
| 115 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58664098 |
| 116 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.58308901 |
| 117 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.58078202 |
| 118 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.57636798 |
| 119 | Hepatitis C_Homo sapiens_hsa05160 | 0.55637939 |
| 120 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.55564481 |
| 121 | Mineral absorption_Homo sapiens_hsa04978 | 0.55309592 |
| 122 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55138039 |
| 123 | Homologous recombination_Homo sapiens_hsa03440 | 0.52828121 |
| 124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52794808 |
| 125 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.52611930 |
| 126 | Protein export_Homo sapiens_hsa03060 | 0.51985209 |
| 127 | HTLV-I infection_Homo sapiens_hsa05166 | 0.50688047 |
| 128 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.47831716 |
| 129 | Focal adhesion_Homo sapiens_hsa04510 | 0.47706044 |
| 130 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.45724239 |
| 131 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.44757215 |
| 132 | Platelet activation_Homo sapiens_hsa04611 | 0.42886322 |
| 133 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.42587342 |
| 134 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.41923537 |
| 135 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41677585 |

